The Incheon District Court partially accepted Samsung Biologics' request for indirect compulsion, ordering the union not to instruct members to halt core processes during a strike. A fine of 20 million won per violation was imposed.
SEOUL, May 6 (Yonhap) -- Unionized workers of Samsung Biologics returned to work...
Unionized workers at Samsung Biologics are in their fifth day of a general strike, the first in the company's history, demanding a 14 percent pay hike and bonuses. Negotiations remain deadlocked as the union prepares to shift to a work-to-rule campaign.
Samsung Biologics union has agreed to return to negotiations on Monday under labor ministry mediation, after its first-ever strike entered day three. The union demands a 14% increase in base and performance pay, a 30 million won one-off cash incentive, and bonuses equal to 20% of annual operating profit. The company has proposed 6.2% and claims the walkout could cause at least 640 billion won in damage, equivalent to half its Q1 sales.
Samsung Biologics union has agreed to return to negotiations on Monday under labor ministry mediation, after the first round of talks failed. The strike, the first in the company's history, is now in its third day with around 2,800 of 4,000 unionized workers walking out. The union demands a 14% increase in base and performance pay, a 30 million won one-off cash incentive per worker, and bonuses equal to 20% of annual operating profit. The company has proposed a 6.2% combined increase and claims the strike could cause at least 640 billion won in damage, equivalent to roughly half of its first-quarter sales.
SEOUL, May 2 (Yonhap) -- Unionized workers at Samsung Biologics, the biotech arm...
Unionized workers at Samsung Biologics began a five-day general strike on May 1, marking the first labor action since the company's 2011 establishment. The union demands a 14% increase in base and performance pay, a 30 million won cash incentive, and bonuses equal to 20% of annual operating profit. The company proposed 6.2% and warned that full-scale strike losses could exceed 640 billion won ($433 million), roughly half of its Q1 sales. The strike has already forced cessation of some batch production of anticancer and HIV treatments, with current losses estimated at 150 billion won.
Unionized workers at Samsung Biologics have launched a five-day strike, the first in the company's history, to demand higher pay. The company warns of significant financial losses and potential operational disruptions, while mediation efforts continue.
Unionized workers at Samsung Biologics launched a five-day general strike on May 1, 2026, marking the first labor walkout in the company's history since its 2011 establishment. The union demands a 14% increase in base and performance-related pay, a 30 million won one-off cash incentive, and bonuses equal to 20% of annual operating profit. The company has proposed 6.2% and warns losses could exceed 640 billion won ($433 million). Negotiations failed after 13 rounds despite a court injunction attempt.
SEOUL, April 22 (Yonhap) -- Samsung Biologics Co., the biotech arm of Samsung Gr...
